Patents by Inventor Roberta Lorenzon

Roberta Lorenzon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11534479
    Abstract: The invention relates to the use of interleukin-2 in treating Sjögren's syndrome in a subject, wherein IL-2 is to be administered at a low dose of less than about 3.5 MIU/day.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: December 27, 2022
    Assignees: ILTOO PHARMA, ASSISTANCE PUBLIQUE—HÖPITAUX DE PARIS, SORBONNE UNIVERSITÉ
    Inventors: David Klatzmann, Roberta Lorenzon, Michèle Rosenzwajg, Patrice Cacoub, Arsene Mekinian
  • Publication number: 20210121532
    Abstract: The invention relates to the use of interleukin-2 in treating Sjögren's syndrome in a subject, wherein IL-2 is to be administered at a low dose of less than about 3.5 MIU/day.
    Type: Application
    Filed: February 18, 2019
    Publication date: April 29, 2021
    Applicants: ILTOO PHARMA, ASSISTANCE PUBLIQUE - HÖPITAUX DE PARIS, SORBONNE UNIVERSITÉ
    Inventors: David KLATZMANN, Roberta LORENZON, Michèle ROSENZWAJG, Patrice CACOUB, Arsene MEKINIAN
  • Publication number: 20190060407
    Abstract: The invention relates to the use of interleukin-2 in treating spondyloarthritis in a human subject, wherein IL-2 is to be administered at a dose of about I to about 2 MIU/day, wherein the treatment comprises at least a first course wherein interleukin-2 is administered once per day during at least 3 consecutive days, followed by a maintenance treatment after 1 to 4 weeks.
    Type: Application
    Filed: September 9, 2016
    Publication date: February 28, 2019
    Applicants: Assistance Publique - Hôpitaux De Paris, ILTOO PHARMA, SORBONNE UNIVERSITE
    Inventors: David Klatzmann, Francis Berenbaum, Jérémie Sellam, Bruno Fautrel, Roberta Lorenzon, Patrice Cacoub